Clinical Case Presentation Template for Peer Discussion

Start with the question the group is being asked to help answer. Then give a compact, de-identified problem representation; a chronological account of the important changes; the findings that support and weaken the leading explanation; the tests and treatments already tried; and the decision or uncertainty that remains. End by naming the next step, owner, and time to review.

This format helps peers reason from the evidence available at each stage instead of anchoring on a memorable outcome. It is a communication template, not a diagnostic algorithm, case-report submission standard, credentialing tool, or substitute for the patient’s ordinary clinical record. Follow local consent, privacy, governance, supervision, and handoff requirements before sharing any case.

A discussion becomes more useful when the presenter states what kind of help is needed. The question might be whether the problem representation is missing a discriminating feature, which competing explanation deserves attention, how to interpret a discordant result, whether a referral or follow-up loop is clear, or how to explain uncertainty to the patient. “What is the diagnosis?” is often too broad and can invite premature closure.

Name the setting and time horizon without naming the patient or institution. Say whether the patient is stable, deteriorating, awaiting a result, or already discharged with a follow-up plan. If urgent escalation is needed, use the local pathway first; a teaching or peer discussion must never delay care.

• What decision, uncertainty, or communication problem should the group address?
• What is the immediate safety or escalation status?
• What would count as a useful answer, and what is outside the scope of this discussion?

Use only the context that changes interpretation: a broad age band when needed, relevant baseline health or risk, the dominant syndrome, tempo, key discriminators, and the reason the case is being discussed. Keep the sentence chronological enough to show what changed. Avoid copying an entire chart or listing every normal result before the group knows the question.

A one-line summary is a starting point, not a compressed diagnosis. Label the status of the working explanation—suspected, supported, confirmed, or uncertain—and avoid turning an untested label into a fact. If an important item is unknown, say unknown; silence can be mistaken for a negative finding.

Give the order of onset, progression, examination, testing, treatment, and response. Relative intervals often protect privacy while preserving reasoning: “three days after,” “during the second week,” or “after the medicine changed.” Include the positives and negatives that actually change the comparison, not a checklist of every body system. Distinguish what was known at the time from what became clear later.

A matched case or retrospective teaching point can make the final explanation feel inevitable. Showing the earlier uncertainty, alternative explanations, and decision points lets the group examine whether the clue was available prospectively. Do not edit the timeline or results to make the case cleaner; suppress or generalize identifying detail without changing the clinical meaning.

• Baseline and onset: what was normal or different before the first meaningful change?
• Sequence: what happened next, and at what relative interval?
• Discriminators: which positives, negatives, exposures, medicines, or examination findings narrow the question?
• Decision points: what was considered, tested, treated, deferred, or handed over—and why?

Use explicit labels such as observed, reported, measured, interpreted, pending, unavailable, or inferred. A phrase like “the scan showed pneumonia” may combine an observation with a conclusion; “the report described a focal opacity, interpreted as…” makes the evidentiary step visible. Note the source and timing of an important result, especially when a later summary may contain hindsight.

Ask the group to challenge the information boundary: which fact would most change the leading explanation, which result has been over-read, and what is being treated as a negative only because it was not recorded? The goal is a better next question, not an artificially complete story.

For each important test, state why it was obtained, what it actually showed, what it did not establish, and whether the result was available before the decision being discussed. A test result can be a clue, a rule-out contribution, a confirmation, or an incidental finding; those are not interchangeable. Use the original report or governed clinical record when precision matters.

For a treatment or intervention, state the indication, timing, dose or approach only when relevant to the peer question, and the observed response. Improvement does not prove the presumed cause, and non-response does not by itself exclude it. Avoid presenting a single case as evidence that a treatment works or that a test should be repeated for everyone.

Close the presentation with the current working explanation, the strongest alternative or time-sensitive concern, what remains unknown, and the next action that would change the plan. Assign ownership and a review time. If a result, referral, callback, or safety-net instruction is pending, state how it will be closed and who will notice if it does not happen.

A peer discussion can surface a missing question or prompt a second look. It cannot authorize care outside the responsible clinician’s scope, local policy, or supervision. Record decisions and patient communication through the ordinary clinical system rather than treating a chat thread as the medical record.

• Working explanation and confidence: what supports it, and what does not fit?
• Alternative or high-consequence concern: what would make it more likely, and what is the time-sensitive trigger?
• Next action: what will happen, who owns it, and by when?
• Loop closure: how will pending results, referrals, or patient questions be tracked?

Remove direct identifiers from the title, prose, attachments, screenshots, filenames, metadata, and links. Then review combinations: exact dates, small-area geography, named facilities, employers, rare occupations, public events, unusual family details, or a distinctive sequence can identify a person even when the name is gone. Inspect images at full resolution for faces, wristbands, labels, barcodes, burned-in text, and recognizable anatomy.

Use the minimum detail needed for the approved audience and purpose. Prefer age bands, broad locations, relative timing, and category-level exposures when they preserve the reasoning. Automated scanners are useful backstops but cannot guarantee de-identification; if the residual risk cannot be made acceptable, do not share the case and seek the responsible privacy or governance review.

• Purpose and audience: who is allowed to see this, and what decision does it support?
• Narrative and files: have identifiers, metadata, links, labels, and rare combinations been removed or generalized?
• Clinical fidelity: did privacy edits preserve anatomy, sequence, results, and treatment meaning?
• Governance: are consent, institutional approval, and local disclosure rules satisfied?

Use this as a prompt in an approved clinical workspace. Keep the completed version in the ordinary governed record when it affects care, and avoid placing patient-identifying details in an unapproved chat or public forum.

• Question: What decision, uncertainty, or learning point should peers address?
• Safety status: Stable, deteriorating, urgent pathway activated, or other local status.
• Problem representation: Broad context, baseline, syndrome, tempo, key discriminators, and current working status.
• Timeline: Onset, sequence, examinations, tests, interventions, responses, handoffs, and what was known at each stage.
• Evidence: Important positives, negatives, pending or unavailable information, and the source and timing of key results.
• Interpretation: Leading explanation, strongest alternative, high-consequence concern, and what does not fit.
• Privacy: Identifiers removed, media and metadata checked, minimum necessary detail used, and governance route confirmed.
• Next step: Action, owner, deadline, escalation trigger, and plan for closing pending results or referrals.

AHRQ communication and diagnostic-safety resources describe structured prompts for making facts, alternatives, missing information, consequences, and next steps visible. HHS describes formal United States HIPAA de-identification routes and examples of identifiers. Those sources do not validate this exact template, prove that peer discussion improves diagnosis or outcomes, or establish a universal privacy rule for every country, specialty, or platform.

This page is an editorial synthesis for education and communication. No named clinician reviewer is assigned. Adapt it through local clinical governance, supervision, consent, privacy, and record-keeping requirements. A discussion is not a diagnosis, treatment recommendation, credentialing decision, or substitute for the care team responsible for the patient.